The current price of GDRX is $3.51 — it has increased by 0.57% since the previous close. Data as of Nov 6, 2026.
GDRX is up 0.57% over the past week, up 8.00% over the past month and up 12.86% over the past year. The price is above its 200-day moving average of $2.84.
Of the 14 analysts covering GoodRx Holdings, Inc., 1 rates it a strong buy, 3 rate it a buy, 8 rate it a hold and 2 rate it a strong sell. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
GoodRx Holdings, Inc. has a market capitalization of $1.2B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, GoodRx Holdings, Inc. posted earnings of $0.08 per share against an estimate of $0.07968, beating expectations by 0.40%. Upcoming reports are listed in the earnings calendar.
GoodRx Holdings, Inc. reported revenue of $200.41M in its most recent quarter, which has decreased by 1.31% compared with the same quarter a year earlier. Analysts had expected $193.23M.
In the latest trading session GDRX moved between $3.33 and $3.55, a range of 6.27% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of GoodRx Holdings, Inc. shows a buy rating today and a neutral rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for GoodRx Holdings, Inc. is neutral. Technical ratings are indicators, not investment advice.
Over the past 52 weeks GDRX has traded between $1.77 and $3.89. The current price is 9.77% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.